FDA Warning Letter — Bioverse, Inc.
The FDA took a Warning Letter action against Bioverse, Inc. on Sep 9, 2025 (New York, NY). The action was issued by CDER and concerns drugs products.
Action details
- Facility
- Bioverse, Inc.
- Date
- Sep 9, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- New York, NY (United States)